These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 16464753)

  • 1. The influence of oxime and anticholinergic drug selection on the potency of antidotal treatment to counteract acute toxic effects of tabun in mice.
    Kassa J
    Neurotox Res; 2006 Jan; 9(1):59-62. PubMed ID: 16464753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of anticholinergic drug and oxime selection on the effectiveness of antidotal treatment against tabun-induced poisoning in mice.
    Kassa J
    Acta Medica (Hradec Kralove); 2002; 45(2):75-8. PubMed ID: 12325456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the potency of newly developed oximes (K074, K075) and currently available oximes (obidoxime, trimedoxime, HI-6) to counteract acute toxic effects of tabun and cyclosarin in mice.
    Kassa J; Humlicek V
    Drug Chem Toxicol; 2008; 31(1):127-35. PubMed ID: 18161512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo evaluation of pyridinium oximes: mode of interaction with acetylcholinesterase, effect on tabun- and soman-poisoned mice and their cytotoxicity.
    Calić M; Vrdoljak AL; Radić B; Jelić D; Jun D; Kuca K; Kovarik Z
    Toxicology; 2006 Feb; 219(1-3):85-96. PubMed ID: 16332406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of the time of antidotal treatment administration on its effectiveness against tabun-induced poisoning in mice.
    Kassa J
    Acta Medica (Hradec Kralove); 2004; 47(2):111-4. PubMed ID: 15446360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of the time of antidotal treatment administration on the potency of newly developed oximes to counteract acute toxic effects of tabun in mice.
    Kassa J
    Acta Medica (Hradec Kralove); 2005; 48(2):87-90. PubMed ID: 16259318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotective effects of currently used antidotes in tabun-poisoned rats.
    Kassa J; Krejèová G
    Pharmacol Toxicol; 2003 Jun; 92(6):258-64. PubMed ID: 12787257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pretreatment with pyridinium oximes improves antidotal therapy against tabun poisoning.
    Lucić Vrdoljak A; Calić M; Radić B; Berend S; Jun D; Kuca K; Kovarik Z
    Toxicology; 2006 Nov; 228(1):41-50. PubMed ID: 16982122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The development of new oximes and the evaluation of their reactivating, therapeutic and neuroprotective efficacy against tabun.
    Kassa J; Kuca K; Karasova J; Musilek K
    Mini Rev Med Chem; 2008 Oct; 8(11):1134-43. PubMed ID: 18855728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An evaluation of therapeutic and reactivating effects of newly developed oximes (K156, K203) and commonly used oximes (obidoxime, trimedoxime, HI-6) in tabun-poisoned rats and mice.
    Kassa J; Karasova J; Musilek K; Kuca K
    Toxicology; 2008 Jan; 243(3):311-6. PubMed ID: 18054821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of the therapeutic and reactivating efficacy of newly developed oximes (K117, K127) and currently available oximes (obidoxime, trimedoxime, HI-6) in tabun-poisoned rats and mice.
    Kassa J; Karasova J; Musilek K; Kuca K; Jung YS
    Drug Chem Toxicol; 2008; 31(3):371-81. PubMed ID: 18622871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New quaternary pyridine aldoximes as casual antidotes against nerve agents intoxications.
    Kuca K; Bartosová L; Jun D; Patocka J; Cabal J; Kassa J; Kunesová G
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2005 Jun; 149(1):75-82. PubMed ID: 16170392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of reactivating efficacy of newly developed oximes (K074, K075) and currently available oximes (obidoxime, HI-6) in cyclosarin-and tabun-poisoned rats.
    Kassa J; Jun D; Kuca K
    J Enzyme Inhib Med Chem; 2007 Jun; 22(3):297-300. PubMed ID: 17674811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of the potency of newly developed oximes (K027, K048) and commonly used oximes (obidoxime, HI-6) to counteract tabun-induced neurotoxicity in rats.
    Kassa J; Kunesova G
    J Appl Toxicol; 2006; 26(4):309-16. PubMed ID: 16552727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticholinergic drugs--functional antidotes for the treatment of tabun intoxication.
    Krejcová G; Kassa J
    Acta Medica (Hradec Kralove); 2004; 47(1):13-8. PubMed ID: 15168875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of the potency of newly developed oximes (K347, K628) and currently available oximes (obidoxime, HI-6) to counteract acute neurotoxic effects of Tabun in rats.
    Kassa J; Karasová JZ; Tesarová S; Musílek K; Kuca K
    Acta Medica (Hradec Kralove); 2010; 53(2):85-91. PubMed ID: 20672744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the potency of newly developed oximes (K074, K075) and commonly used oximes (obidoxime, HI-6) to counteract tabun-induced neurotoxicity in rats.
    Kassa J; Karasova J
    Toxicology; 2007 Jan; 229(1-2):136-44. PubMed ID: 17141392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of antidotal treatment of low-level tabun exposure on cognitive functions in rats using a water maze.
    Kassa J; Kunesova G
    Neurotox Res; 2006 Jan; 9(1):39-45. PubMed ID: 16464751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro reactivation of tabun-inhibited acetylcholinesterase using new oximes--K027, K005, K033 and K048.
    Kuca K; Cabal J
    Cent Eur J Public Health; 2004 Mar; 12 Suppl():S59-61. PubMed ID: 15141981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of reactivating and therapeutic efficacy of the oxime K203 and its fluorinated analog (KR-22836) with currently available oximes (obidoxime, trimedoxime, HI-6) against tabun in rats and mice.
    Kassa J; Karasova JZ; Caisberger F; Musilek K; Kuca K; Jung YS
    J Enzyme Inhib Med Chem; 2010 Aug; 25(4):480-4. PubMed ID: 20233085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.